Current Cancer Drug Targets
Title: Editorial [ Hot Topic:Biology in Anticancer Treatment (Guest Editor: Bruno Vincenzi)]
Volume: 10 Issue: 1
Author(s): Bruno Vincenzi
Affiliation:
Export Options
About this article
Cite this article as:
Vincenzi Bruno, Editorial [ Hot Topic:Biology in Anticancer Treatment (Guest Editor: Bruno Vincenzi)], Current Cancer Drug Targets 2010; 10 (1) . https://dx.doi.org/10.2174/156800910790980214
DOI https://dx.doi.org/10.2174/156800910790980214 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
16
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Quantum Dot-Based Nanoprobes for In Vivo Targeted Imaging
Current Molecular Medicine Membrane Permeable Lipophilic Cations as Mitochondrial Directing Groups
Current Topics in Medicinal Chemistry Cyclooxygenase-2 Inhibitors: A Painful Lesson
Cardiovascular & Hematological Disorders-Drug Targets Turning Tumor-Promoting Copper into an Anti-Cancer Weapon via High-Throughput Chemistry
Current Medicinal Chemistry Patent Selections
Recent Patents on Biomarkers Gene Therapy Approaches for the Selective Killing of Cancer Cells
Current Pharmaceutical Design Preface: MicroRNA as Disease Biomarkers
MicroRNA Insulin-Like Growth Factor 2 - The Oncogene and its Accomplices
Current Pharmaceutical Design Enhancement of the Antiproliferative Activity of Gemcitabine by Modulation of c-Met Pathway in Pancreatic Cancer
Current Pharmaceutical Design Biomarkers of Protein Oxidation in Human Disease
Current Molecular Medicine Insulin-like Growth Factor-1 Receptor (IGF-1R) Kinase Inhibitors in Cancer Therapy: Advances and Perspectives
Current Pharmaceutical Design MICA Molecules in Disease and Transplantation, a Double-Edged Sword?
Current Immunology Reviews (Discontinued) Application of Serial Analysis of Gene Expression in Cancer Research
Current Pharmaceutical Biotechnology Attenuated Oncolytic Measles Virus Strains as Cancer Therapeutics
Current Pharmaceutical Biotechnology Identification of Marker Genes for Cancer Based on Microarrays Using a Computational Biology Approach
Current Bioinformatics Development of Pin1 Inhibitors and their Potential as Therapeutic Agents
Current Medicinal Chemistry Electronic Noses in Medical Diagnostics
Current Medicinal Chemistry The Development of New Concepts for Assessing Reproductive Toxicity Applicable to Large Scale Toxicological Programmes
Current Pharmaceutical Design Cancer Targeted Therapy Strategy: The Pathologist’s Perspectives
Current Cancer Drug Targets Updated Review and Perspective on 20S Proteasome Inhibitors in the Treatment of Lung Cancer
Current Cancer Drug Targets